Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.41 |
| ▸ | CTSD | P07339 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL475201 | 1.00 | CYP1A2 (0.72) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL4726270 | 0.88 | CYP1A2 (0.68) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL4726276 | 0.88 | CYP1A2 (0.68) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL7736134 | 0.86 | CYP1A2 (0.57) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL10505139 | 0.86 | CYP1A2 (0.57) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL7732976 | 0.86 | CYP1A2 (0.57) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL9479735 | 0.85 | CYP1A2 (0.74) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL3969391 | 0.85 | CYP1A2 (0.65) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL3969388 | 0.85 | CYP1A2 (0.65) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL11624953 | 0.84 | CYP1A2 (0.57) | CYP1A2TSHRALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411510-A2 | CAL A-RELATED ACYLTRANSFERASES AND METHODS OF USE, THEREOF | Danisco US Inc. (US) | 2012-02-01 | — | — | EP | claimed |
| WO-2010111143-A2 | CAL A-RELATED ACYLTRANSFERASES AND METHODS OF USE, THEREOF | DANISCO US INC. (US) | 2010-09-30 | — | — | WO | claimed |
| CN-121735779-A | New synthetic preparation method of medical intermediate 2- (4-nitrophenyl) butyric acid | 内蒙古宜达化学科技有限公司 | 2026-03-27 | — | — | CN | disclosed |
| CN-119395197-A | Detection method of genotoxic impurity o-methylbenzaldehyde in indobufen | 湖南方盛制药股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| WO-2024098050-A1 | CURVED OPTICAL DEVICES, AND METHODS FOR MAKING SAME | ALPHAMICRON INCORPORATED (US) | 2024-05-10 | — | — | WO | disclosed |
| CN-117844523-A | Separation method of low-rank coal white rot fungi liquefied products | 黔南民族师范学院 | 2024-04-09 | — | — | CN | disclosed |
| WO-2024073046-A1 | PHOTOVOLTAIC STRUCTURES HAVING A COMPOSITE CONDUCTOR | ENERGY MATERIALS CORPORATION (US) | 2024-04-04 | — | — | WO | disclosed |
| CN-114516799-B | Synthesis method of indobufen key intermediate 2- (4-nitrophenyl) butyric acid | 杭州中美华东制药有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-114380694-B | Synthesis method for preparing indobufen intermediate by continuous flow | 拓信达(启东)医药生物科技有限公司 | 2024-02-09 | — | — | CN | disclosed |
| US-11414641-B2 | Article and method for detecting aerobic bacteria | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-08-16 | — | — | US | disclosed |
| CN-114516799-A | Synthesis method of indobufen key intermediate 2- (4-nitrophenyl) butyric acid | 杭州中美华东制药有限公司 | 2022-05-20 | — | — | CN | disclosed |
| US-5188937-A | Binding of signal antibody to antigen | BECTON, DICKINSON AND COMPANY (US) | 1993-02-23 | — | — | US | disclosed |
| EP-0501526-A2 | Fluoroketones as blocked enzyme inhibitors for use in immunoassays | Becton, Dickinson and Company (US) | 1992-09-02 | — | — | EP | disclosed |
| US-4962024-A | ADDING SECOND ENZYME AND BLOCKED FLUOROKETONE INHIBITOR OF THE SECOND ENZYME | BECTON, DICKINSON AND COMPANY (US) | 1990-10-09 | — | — | US | disclosed |
| EP-0369657-A2 | Chromogenic substrate for esterase and immunoassay using same | Becton, Dickinson and Company (US) | 1990-05-23 | — | — | EP | disclosed |
| EP-0369361-A2 | Immunoassay on a preblocked solid surface | Becton, Dickinson and Company (US) | 1990-05-23 | — | — | EP | disclosed |
| US-4835099-A | Signal enhancement in immunoassay by modulation of enzymatic catalysis | BECTON, DICKINSON AND COMPANY (US) | 1989-05-30 | — | — | US | disclosed |
| EP-0271731-A2 | Signal enhancement in immunoassay by inhibition of enzymatic catalysis | Becton, Dickinson and Company (US) | 1988-06-22 | — | — | EP | disclosed |
| EP-0268452-A2 | Novel hydrolase and method of production | GENENCOR, INC. (US) | 1988-05-25 | — | — | EP | disclosed |
| EP-0268456-A2 | Enzymatic peracid bleaching system | The Clorox Company (US) | 1988-05-25 | — | — | EP | disclosed |